Who owns THERIVA BIOLOGICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Theriva Biologics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Theriva Biologics stock

Who bought or sold THERIVA BIOLOGICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 256k $54k 1461% Dec 2025
 View chart
Geode Capital Management 212k $45k 652% Dec 2025
 View chart
UBS Group 191k $40k 735% Dec 2025
 View chart
Ikarian Capital 112k $24k -7% Dec 2025
 View chart
Two Sigma Investments 62k $25k 100% Sep 2025
 View chart
Two Sigma Securities 43k $9.0k 100% Dec 2025
 View chart
DRW Holdings 42k $8.8k 100% Dec 2025
 View chart
XTX Topco 39k $8.3k 20% Dec 2025
 View chart
Intl Fcstone 37k $7.8k 100% Dec 2025
 View chart
Barclays 33k $6.9k 100% Dec 2025
 View chart
Boothbay Fund Management 28k $5.8k -22% Dec 2025
 View chart
Two Sigma Advisers 27k $11k 100% Sep 2025
 View chart
Schwarz Dygos Wheeler Investment Advisors 15k $3.2k 100% Dec 2025
 View chart
BlackRock 7.5k $1.6k 0% Dec 2025
 View chart
Advisor Group Holdings 448.00 $149.318400 1% Dec 2025
 View chart
SBI Securities 59.00 $12.000600 0% Dec 2025
 View chart
IFP Advisors 11.00 $1.999800 0% Dec 2025
 View chart
Newbridge Financial Services Group 5.00 $1.000000 100% Dec 2025
 View chart
Danske Bank A/s 1.00 $0 0% Dec 2025
 View chart

Who sold out of Theriva Biologics?

Fund or Company Name Date Sold Shares Held Valued At
Virtu Financial Sep 2025 37k $15k
Jane Street Sep 2025 37k $15k
Citadel Advisors Jun 2025 36k $16k
Hrt Financial Sep 2025 10k $4.0k
FMR Jun 2025 3.0k $1.3k
Sontag Advisory Sep 2025 2.00 $1.000000